Literature Characteristics and Design Elements of the Comprehensive Evaluation of Chinese Herbal Medicine Using the Multi-criteria Decision Analysis Method

Ruyu XIA; Xuejing JIN; Qianyun CHAI; Yutong FEI; Jianping LIU

doi:10.13288/j.11-2166/r.2022.02.005

您当前的位置：

首页 >

文章列表页 >

Literature Characteristics and Design Elements of the Comprehensive Evaluation of Chinese Herbal Medicine Using the Multi-criteria Decision Analysis Method

更新时间：2022-01-14

- Literature Characteristics and Design Elements of the Comprehensive Evaluation of Chinese Herbal Medicine Using the Multi-criteria Decision Analysis Method
- Journal of Traditional Chinese Medicine Vol. 63, Issue 2, Pages: 119-124(2022)
- 作者机构：
  
  1.北京中医药大学循证医学中心，北京市朝阳区北三环东路11号，100029
  2.北京中医药大学国际循证中医药研究院
  3.北京GRADE中心
- 作者简介：
- 基金信息：
- DOI：10.13288/j.11-2166/r.2022.02.005
  CLC：
- Received：21 January 2021，
  
  Revised：2021-08-05，
  
  Published：17 January 2022
- 稿件说明：
移动端阅览
夏如玉,金雪晶,柴倩云等.运用多准则决策分析法的中药临床综合评价文献特征分析及设计要点[J].中医杂志,2022,63(02):119-124.

XIA Ruyu,JIN Xuejing,CHAI Qianyun,et al.Literature Characteristics and Design Elements of the Comprehensive Evaluation of Chinese Herbal Medicine Using the Multi-criteria Decision Analysis Method[J].Journal of Traditional Chinese Medicine,2022,63(02):119-124.
夏如玉,金雪晶,柴倩云等.运用多准则决策分析法的中药临床综合评价文献特征分析及设计要点[J].中医杂志,2022,63(02):119-124. DOI： 10.13288/j.11-2166/r.2022.02.005.

XIA Ruyu,JIN Xuejing,CHAI Qianyun,et al.Literature Characteristics and Design Elements of the Comprehensive Evaluation of Chinese Herbal Medicine Using the Multi-criteria Decision Analysis Method[J].Journal of Traditional Chinese Medicine,2022,63(02):119-124. DOI： 10.13288/j.11-2166/r.2022.02.005.

摘要

目的

分析运用多准则决策分析法（MCDA）进行中药临床综合评价研究的文献特征和方法学现状，为今后研究者设计和实施中药MCDA研究提供建议。

方法

计算机检索PubMed、The Cochrane Library、EMbase、SinoMed及中国知网（CNKI）、维普数据库（CQVIP）、万方数据库，获取自各数据库建库至2020年11月20日发表的运用MCDA进行中药临床综合评价研究的文献。由两名研究者完成文献筛选，提取文献基本特征、决策背景、准则类别、评分方法、权重赋值方法等特征资料，并进行描述分析。

结果

共纳入中文文献5篇，发表时间为2017年至2020年。纳入研究涉及疾病包括关节炎和急性上呼吸道感染，涉及中药包括口服乌头（3篇）、雷公藤制剂（3篇）和双黄连注射剂（1篇），其中2篇同时涉及乌头和雷公藤制剂。纳入研究只选择疗效和安全性准则，未涉及中药经济性、可及性等指标，文献均使用摆幅权重法（SWING法）赋予权重，将临床数据转化为线性函数再进行加权。所有研究均未报告权重赋值及评分人员的信息，未对证据的方法学质量进行评价和报告。

结论

MCDA用于中药临床综合评价尚处于探索阶段，目前应用研究涵盖的疾病和干预措施种类非常有限，方法学信息报告也存在不足。需要更多相关方法学研究针对利益相关者和准则的选择、评价过程中利益相关者观点的共识等难点进行研究。

Abstract

Objective

To analyze the literature characteristics and design methodology of comprehensive evaluation researches on Chinese herbal medicine （CHM） using multi-criteria decision analysis （MCDA） method， and to provide references for future design and implementation of MCDA in CHM researches.

Methods

Electronic databases including PubMed， Cochrane Library， EMbase， SinoMed， CNKI， CQVIP and Wanfang were searched from the inception dates to November 20th， 2020 for literature on comprehensive evaluation of CHM by using MCDA method. Two researchers independently screened the literature， extracted the data including basic characteristics， decision background， criteria category， evaluation method， weighting method and others， and performed descriptive analyses.

Results

A total of five Chinese papers publishing between 2017 and 2020 were included. The involved diseases were arthritis and acute upper respiratory tract infection， and the evaluated CHM were oral Wutou （

AconitumcarmichaeliDebx

）（3 papers）， Leigongteng （

Radix Tripterygii Wilfordii

） preparations （3 papers）， and

Shuanghuanglian

（双黄连） Injections （1 paper）； Wutou and Leigongteng preparations were evaluated simultaneously in two papers. Only criteria on effectiveness and safety were designed in the included papers， while economy and accessibility indicators were not involved. All the papers used SWING weighting method， trying to convert the clinical data into linear functions and then weighted them. All the papers did not report the weight assignment and scorer information， and did not evaluate and report the methodological quality of the evidence.

Conclusion

It is still in the initial exploration phase of comprehensive evaluation of CHM using MCDA method， with few diseases and interventions having been evaluated and lack of methodological information reports. Therefore， more methodological researches are needed to solve the problems such as the selection of stakeholders and criteria， and the consensus-reaching of different stakeholders in the evaluation process.

关键词

Keywords

references

国家卫健委药物政策与基本药物制度司 . 国家卫生健康委关于开展药品使用监测和临床综合评价工作的通知［EB/OL］. （ 2019-04-09 ）［ 2020-12-14 ］. http：//www.nhc.gov.cn/yaozs/pqt/201904/31149bb1845e4c019a04f30c0d69c2c9.shtml http://www.nhc.gov.cn/yaozs/pqt/201904/31149bb1845e4c019a04f30c0d69c2c9.shtml .

BROEKHUIZEN H ， GROOTHUIS-OUDSHOORN CGM ， VAN TIL JA ， et al . A review and classification of approaches for dealing with uncertainty in multi-criteria decision analysis for healthcare decisions ［J］. Pharmacoeconomics ， 2015 ， 33 （ 5 ）： 445 - 455 .

MUHIBACHER AC ， KACZYNSKI A . Making good decisions in healthcare with multi-criteria decision analysis： the use， current research and future development of MCDA ［J］. Appl Health Econ Hea ， 2016 ， 14 （ 1 ）： 29 - 40 .

国家药典委员会 . 中华人民共和国药典：一部［Ｍ］. 北京：中国医药科技出版社， 2015 .

薛慧颖，喻兆阳，李娟 . 2019年版《国家基本医疗保险、工伤保险和生育保险药品目录》解读［J］. 医药导报， 2020 ， 39 （ 1 ）： 1 - 9 .

洪海都，刘城鑫，吴鹏，等 . 治疗咳嗽中成药的挖掘与分析［J］. 中成药， 2019 ， 41 （ 10 ）： 2536 - 2540 .

PEACOCK S ， MITTON C ， BATE A ， et al . Overcoming barriers to priority setting using interdisciplinary methods ［J］. Health Policy ， 2009 ， 92 （ 2-3 ）： 124 - 132 .

姜皓，张晓朦，张冰，等 . 基于多准则决策的雷公藤多苷片治疗类风湿关节炎效益-风险评价［J］. 中国中药杂志， 2020 ， 45 （ 4 ）： 798 - 808 .

张晓朦，金勇男，张冰，等 . 川草乌治疗类风湿性关节炎的效益-风险评价［J］. 中国中药杂志， 2018 ， 43 （ 2 ）： 234 - 241 .

张晓朦，林志健，张冰，等 . 含乌头、雷公藤中药制剂治疗中轴脊柱关节炎的效益与风险对比研究［J］. 中国药物警戒， 2018 ， 15 （ 2 ）： 103 - 109 .

张晓朦，林志健，张冰，等 . 乌头、雷公藤治疗强直性脊柱炎的效益-风险评价［C］ //国家食品药品监督管理总局药品评价中心. 第六届中国药物警戒大会论文集 . 杭州：国家食品药品监督管理总局药品评价中心， 2017 ： 10 - 17 .

卢颖，王斯玥，刘畅，等 . 基于MCDA模型构建中药注射剂效益风险评价体系：以双黄连注射剂治疗急性上呼吸道感染为例［J］. 药物流行病学杂志， 2017 ， 26 （ 7 ）： 499 - 501 .

GOOYERT VD ， EAJAROUWETTE ， KRANENBURG HV ， et al . Reviewing the role of stakeholders in operational research： a stakeholder theory perspective ［J］. Eur J Oper Res ， 2017 ， 262 （ 2 ）： 402 - 410 .

NACI H ， VALKENHOEF GV ， HIGGINS JPT ， et al . Evidence-based prescribing combining network meta-analysis with multicriteria decision analysis to choose among multiple drugs ［J］. Circ Cardiovasc Qual ， 2014 ， 7 （ 5 ）： 787 - 792 .

VAN TIL J ， GROOTHUSI-OUDSHOOM C ， LIEFERINK M ， et al . Does technique matter； a pilot study exploring weighting techniques for a multi-criteria decision support framework ［J］. Cost Eff Resour Alloc ， 2014 ， 12 ： 22 . doi： 10.1186/1478-7547-12-22 http://dx.doi.org/10.1186/1478-7547-12-22 .

PHILLIPS LD ， BANA-E-COSTA CA . Transparent prioritisation， budgeting and resource allocation with multi-criteria decision analysis and decision conferencing ［J］. Ann Oper Res ， 2007 ， 154 （ 1 ）： 51 - 68 .

GOETGHEBEUR MM ， WAGNER M ， KHOURY H ， et al . Evidence and value： impact on decision making： the EVIDEM framework and potential applications ［J］. BMC Health Serv Res ， 2008 ， 8 ： 270 . doi： 10.1186/1472-6963-8-270 http://dx.doi.org/10.1186/1472-6963-8-270 .

查看原文

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Summary and Evaluation of Clinical Evidence for Toutongning Capsules （头痛宁胶囊） in Treatment of Patients with Migraine

Studies on the Network Toxicology and Immunological Mechanism of Chinese Herbal Medicine-Induced Acute Kidney Injury

Current Situation and Suggestion of Comprehensive Clinical Evaluation of Medical Products in China in Recent Ten Years

Overview of Research in Traditional Chinese Medicine for the Treatment of Depression by Intervention on TLR4/NLRP3 Signaling Pathway

Challenges and Recommendations for Implementing Key Technologies in Decentralized Clinical Trials of Traditional Chinese Medicine

Related Author

XIE Yanming

SUN Chunquan

WANG Fengchen

ZHU Xiaoxia

QIN Ying

WANG Lianxin

LUAN Xiangjia

YANG Shuo

Related Institution

Guang'anmen Hospital Jinan Hospital，China Academy of Chinese Medical Sciences/ Jinan Municipal Hospital of Traditional Chinese Medicine

Tsinghua University Yuquan Hospital/ Integrated Chinese and Western Medicine Hospital of Tsinghua University

Institute of Basic Research in clinical Medicine，China Academy of Chinese Medical Sciences

Institute of Basic Research in Clinical Medicine，China Academy of Chinese Medical Science

Guang'anmen Hospital，China Academy of Chinese Medical Science

Address：No.16, Nanxiao street, Dongzhimen, Dongcheng District, Beijing Postal code：100700
Tel：010-64035632 Email：jtcmcn@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备09064830号-19 京公网安备11010102007558号
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰